Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Deanna M. Langfitt"'
Autor:
Matthew Bauler, Francesca Ferrara, Brandon Lowe, Jordan A. Beard, Chris Wincek, Matthew M. Wielgosz, Jeoungeun J. Park, Na Shang, Saikat Nandy, Cai Li, Deanna M. Langfitt, Sheng Zhou, Robert E. Throm
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 2, Pp 101270- (2024)
Successful cell and gene therapy clinical trials have resulted in the US Food and Drug Administration and European Medicines Agency approving their use for treatment of patients with certain types of cancers and monogenetic diseases. These novel ther
Externí odkaz:
https://doaj.org/article/9d1dc059d1bc47cf8fa9972dc0d7bc28
Autor:
Abdullah Freiwan, Jaquelyn T. Zoine, Jeremy Chase Crawford, Abishek Vaidya, Stefan A. Schattgen, Jacquelyn A. Myers, Sagar L. Patil, Mahsa Khanlari, Hiroto Inaba, Jeffery M. Klco, Charles G. Mullighan, Giedre Krenciute, Peter J. Chockley, Swati Naik, Deanna M. Langfitt, Maksim Mamonkin, Esther A. Obeng, Paul G. Thomas, Stephen Gottschalk, M. Paulina Velasquez
Publikováno v:
Blood. 140(25)
Chimeric antigen receptor (CAR) T-cell therapy targeting T-cell acute lymphoblastic leukemia (T-ALL) faces limitations such as antigen selection and limited T-cell persistence. CD7 is an attractive antigen for targeting T-ALL, but overlapping express
Autor:
Swati Naik, Renee M. Madden, Amanda Lipsitt, Timothy Lockey, Jennyfer Bran, Jeffrey E. Rubnitz, Jeffery Klco, Barry Shulkin, Sagar L. Patil, Sarah Schell, Jeoungeun John Park, Janice Riberdy, Na Shang, Jaquelyn T. Zoine, Jennifer Wallace, Elaine Harstead, Catherine Willis, Jean-Yves Metais, Deanna M. Langfitt, Sheng Zhou, Salem M. Akel, Michael M. Meagher, Brandon M. Triplett, Stephen Gottschalk, Mireya Paulina Velasquez
Publikováno v:
Blood. 140:4584-4585
Autor:
Jaquelyn T. Zoine, Sarah E. Moore, Kalyan Immadisetty, Shams Akel, Deanna M Langfitt, Jorge Ibanez-Vega, Lindsay Talbot, Chris DeRenzo, Giedre Krenciute, M. Madan Babu, Mireya Paulina Velasquez
Publikováno v:
Blood. 140:4506-4507
Publikováno v:
Infection and Immunity. 79:4438-4446
We demonstrate that 2-month-old female B10.T(6R) mice are highly resistant to systemic infection with the KIM5 strain of Yersinia pestis and that B10.T(6R) mice become susceptible to Y. pestis infection by the age of 5 months. In this study, young (2